Total Payments
$27,320
2024 Payments
$559.99
Companies
15
Transactions
155
Medicare Patients
2,529
Medicare Billing
$1.2M
Payment Breakdown by Category
Research$15,298 (56.0%)
Other$6,640 (24.3%)
Food & Beverage$4,694 (17.2%)
Travel$457.40 (1.7%)
Education$230.38 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,298 | 1 | 56.0% |
| Grant | $6,250 | 1 | 22.9% |
| Food and Beverage | $4,694 | 127 | 17.2% |
| Travel and Lodging | $457.40 | 4 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $390.45 | 19 | 1.4% |
| Education | $230.38 | 3 | 0.8% |
Payments by Type
Research
$15,298
1 transactions
General
$12,022
154 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $15,298 | 1 | $0 (2019) |
| Medtronic USA, Inc. | $7,122 | 27 | $0 (2020) |
| Abbott Laboratories | $1,287 | 15 | $0 (2024) |
| Boston Scientific Corporation | $1,055 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $422.28 | 18 | $0 (2021) |
| Medtronic, Inc. | $401.93 | 4 | $0 (2022) |
| Acorda Therapeutics, Inc | $390.45 | 19 | $0 (2021) |
| Allergan, Inc. | $355.61 | 23 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $345.25 | 10 | $0 (2022) |
| Merz Pharmaceuticals, LLC | $285.31 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $559.99 | 5 | Boston Scientific Corporation ($457.02) |
| 2023 | $313.78 | 3 | Boston Scientific Corporation ($176.26) |
| 2022 | $829.26 | 14 | Medtronic, Inc. ($319.01) |
| 2021 | $895.19 | 39 | Merz Pharmaceuticals, LLC ($252.97) |
| 2020 | $296.52 | 14 | Acorda Therapeutics, Inc ($188.95) |
| 2019 | $15,946 | 24 | Eli Lilly and Company ($15,298) |
| 2018 | $899.29 | 29 | Medtronic USA, Inc. ($262.33) |
| 2017 | $7,580 | 27 | Medtronic USA, Inc. ($6,609) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $166.05 | General |
| Category: General - DBS_NMD | ||||||
| 09/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $165.54 | General |
| Category: General - DBS_NMD | ||||||
| 09/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $125.43 | General |
| Category: General - DBS_NMD | ||||||
| 04/12/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $68.94 | General |
| Category: Neuromodulation | ||||||
| 11/03/2023 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $52.47 | General |
| Category: Vercise_NMD | ||||||
| 04/23/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $137.52 | General |
| Category: Neuromodulation | ||||||
| 01/19/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $123.79 | General |
| Category: General - DBS_NMD | ||||||
| 12/21/2022 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $169.50 | General |
| Category: Neuromodulation | ||||||
| 09/28/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $7.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/03/2022 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $234.58 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 07/01/2022 | Medtronic, Inc. | ACTIVA PC (Device) | Food and Beverage | In-kind items and services | $84.43 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 06/24/2022 | Boston Scientific Corporation | General - DBS (Device) | Food and Beverage | In-kind items and services | $83.43 | General |
| Category: General - DBS_NMD | ||||||
| 06/16/2022 | Boston Scientific Corporation | General - DBS (Device) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: General - DBS_NMD | ||||||
| 06/14/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $61.22 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/20/2022 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Musculoskeletal | ||||||
| 05/19/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/17/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/28/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Neuropsychiatry | ||||||
| 03/25/2022 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Neuropsychiatry | ||||||
| 02/15/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/13/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/10/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Musculoskeletal | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY | Eli Lilly and Company | $15,298 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 570 | 46,305 | $1.2M | $291,074 |
| 2022 | 11 | 597 | 41,762 | $1.2M | $279,701 |
| 2021 | 11 | 665 | 49,639 | $1.3M | $320,905 |
| 2020 | 16 | 697 | 52,673 | $1.2M | $316,913 |
Total Patients
2,529
Total Services
190,379
Medicare Billing
$1.2M
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 52 | 37,260 | $701,309 | $176,676 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 448 | $158,508 | $40,414 | 25.5% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 11 | 8,100 | $121,877 | $32,421 | 26.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 32 | 88 | $88,968 | $13,794 | 15.5% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 25 | 64 | $62,895 | $8,923 | 14.2% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 24 | 56 | $42,104 | $5,395 | 12.8% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 49 | 89 | $12,460 | $3,468 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $13,369 | $3,276 | 24.5% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 33 | 75 | $9,075 | $2,547 | 28.1% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 11 | 27 | $12,771 | $2,082 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $5,500 | $1,408 | 25.6% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 40 | 47 | $4,700 | $669.51 | 14.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 51 | 40,790 | $761,055 | $193,218 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 271 | 447 | $159,048 | $41,378 | 26.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 28 | 84 | $83,630 | $13,337 | 15.9% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 25 | 65 | $63,318 | $9,442 | 14.9% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 26 | 64 | $48,843 | $6,198 | 12.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 50 | 92 | $13,064 | $3,659 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 48 | $12,144 | $3,315 | 27.3% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 14 | 39 | $18,564 | $3,073 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $12,064 | $2,948 | 24.4% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2022 | 34 | 72 | $8,928 | $2,640 | 29.6% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 28 | 35 | $3,500 | $492.21 | 14.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 69 | 48,646 | $876,820 | $226,335 | 25.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 273 | 410 | $142,750 | $40,148 | 28.1% |
About Arjun Tarakad
Arjun Tarakad is a Neurology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1962793661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arjun Tarakad has received a total of $27,320 in payments from pharmaceutical and medical device companies, with $559.99 received in 2024. These payments were reported across 155 transactions from 15 companies. The most common payment nature is "" ($15,298).
As a Medicare-enrolled provider, Tarakad has provided services to 2,529 Medicare beneficiaries, totaling 190,379 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Houston, TX
- Active Since 04/28/2011
- Last Updated 02/12/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1962793661
Products in Payments
- ACTIVA (Device) $7,205
- DBS IPGs (Device) $866.38
- INBRIJA (Drug) $390.45
- INFINITY (Device) $375.96
- NUPLAZID (Drug) $345.25
- Xeomin (Biological) $285.31
- BOTOX (Biological) $241.21
- PERCEPT PC BRAINSENSE (Device) $234.58
- VERCISE (Device) $177.62
- XEOMIN (Biological) $167.44
- AUSTEDO (Drug) $165.70
- BOTOX THERAPEUTIC (Biological) $148.43
- GENERAL DBS (Device) $111.78
- General - DBS (Device) $109.85
- ACTIVA PC (Device) $84.43
- Vercise (Device) $52.47
- INGREZZA (Drug) $45.60
- Infinity DBS Pulse Generators (Device) $44.94
- ONGENTYS (Drug) $36.95
- SD809-HD (Drug) $34.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Houston
William Ondo, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Annette Howard, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M
Paul Schulz, M.d, M.D
Neurology — Payments: $943,067
Neurology $943,067
Amit Verma, Md, MD
Neurology — Payments: $817,815
Neurology $817,815
Dr. Randolph Evans, Md, MD
Neurology — Payments: $715,948
Neurology $715,948
Dr. John Volpi, Md, MD
Neurology — Payments: $569,676
Neurology $569,676